Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells.

ABSTRACT:

SUBMITTER: Parente-Ribes A 

PROVIDER: S-EPMC4938324 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature